Developer docs
API playgroundTry for free, no card

Search company profiles

Genome Medical

Full company profile

uuid000094a

Namestring
Genome Medical
Legal namestring
Genome Medical, Inc.
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Genome Medical is a telehealth-enabled genetics care delivery company headquartered in South San Francisco, California. Founded in 2016, the company operates a nationwide telegenomics platform delivering genetic counseling, genetic test ordering, peer-to-peer provider support, clinical trial matching, and patient recruitment services across all 50 U.S. states. The company serves four primary customer segments: hospitals and health systems seeking to expand access to genetic services without building in-house capacity; life sciences organizations pursuing patient recruitment and clinical trial matching for genetic therapies; genetic testing laboratories requiring pre- and post-test counseling support; and individual patients and families navigating rare disease diagnoses—more than 50% of whom present with a rare disease indication. Genome Medical employs a clinical team of 35+ genetic counselors, medical geneticists, and physicians with an average of 10+ years of clinical experience and has delivered over 250,000 genetic counseling sessions with a 96% patient satisfaction rating.

The core technology is a HIPAA-compliant virtual medical practice platform that integrates telehealth (phone or video) genetic counseling, test ordering integrated with most major genetic testing laboratories, and a patient portal for scheduling and records management. Genome Medical acquired GeneMatters in August 2021 and operates it as a wholly-owned subsidiary. Revenue is generated through multiple streams: insurance billing as an in-network provider with major commercial health plans (Aetna, Anthem, BlueCross BlueShield, Cigna, United Healthcare); self-pay genetic counseling sessions at $250 each; and partnership agreements with health systems, genetic testing laboratories, and biopharmaceutical companies for sponsored testing programs, patient recruitment, and clinical trial feasibility analysis. Government-affiliated insurance (Medicaid, Medicare, Tricare) is not accepted.

Genome Medical has raised approximately $195 million across eight disclosed funding rounds from 2016 through 2024, including a $60 million Series C in August 2021 and an approximately $75.3 million exempt securities offering in September 2024. Notable institutional investors include Canaan Partners, Casdin Capital, Echo Health Ventures, Samsung Catalyst Fund, GE Ventures, Kaiser Permanente Ventures, Illumina Ventures, Google Ventures, and Amgen Ventures. The 2024 capital is allocated to expand services across the U.S. and into Canada, scale operations, enhance genetic counseling capacity, and develop partnerships with health systems, laboratories, and biopharmaceuticals. Leadership includes CEO Jill Davies alongside founders Lisa Alderson, Robert Green, and Randy Scott (Chairman).

Short descriptiontext

Genome Medical is a telehealth-enabled genetics care delivery company providing genetic counseling, test ordering, clinical trial matching, and patient recruitment across all 50 U.S. states, serving hospitals, life sciences organizations, genetic testing labs, and individual patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSouth San Francisco, United States
HQ citystring
South San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
telehealth genetic counseling, genomic medicine services, genetic test ordering, clinical trial matching, rare disease diagnostics
Industry4 codes
PRIMARYHLALAHAK
Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAANAL
Population Genomics & Preventive Precision Health Programs
NAICS code3 codes
  • Medical and Diagnostic Laboratories6215
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code3 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
  • Services-Medical Laboratories8071
Product category
Telehealth Genetic Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Genetic Counseling Services
TypeSubscription Recurring
Description

Genome Medical bills insurance for genetic counseling sessions as an in-network provider with most commercial health insurance plans. Patients can also self-pay at $250 per session. The company also offers sponsored testing programs for life sciences partners, generating revenue through partnership agreements with health systems, genetic testing labs, and biopharmaceutical companies for patient recruitment and clinical trial matching services.

genomemedical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Insurance-billed genetic counseling session
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Patients with in-network commercial insurance coverage can have Genome Medical bill their insurance directly. Coverage and patient responsibility vary by plan. In-network with major plans including Aetna, Anthem, BlueCross BlueShield, Cigna, United Healthcare, and many others.

genomemedical.com
2Self-pay genetic counseling session
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$250 self-pay option per session for individuals without insurance or preferring to pay out-of-pocket. Appointments are 30-60 minutes via phone. Cost does not include genetic testing, which may result in a separate bill from the testing laboratory.

genomemedical.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1GeneMatters
Description

A telehealth genetic counseling platform acquired by Genome Medical in 2021, now operating as a Genome Medical company.

genomemedical.com
Core offering1 text field

Genome Medical is a telehealth-enabled genetics care delivery company providing virtual genetic counseling, genetic test ordering, and clinical trial matching services across all 50 U.S. states. The company delivers board-certified genetic counseling sessions via phone or video, integrates with major genetic testing laboratories to order tests, and partners with life sciences organizations to recruit patients for clinical trials. Its core clientele includes patients with rare diseases, hospitals and health systems, genetic testing laboratories, and biopharmaceutical companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Patients can meet with a genetic counselor within one week — compared to months-long waits typical of in-person genetics appointments.
+3 more records
Product overview1 text field

Genome Medical is a telehealth-enabled genetics care delivery company offering a platform of genetic services. The core offerings include Genetic Counseling (telehealth sessions with board-certified genetic counselors), Genetic Test Ordering (ordering tests through partnered labs), Clinical Trial Services (matching patients to trials), Peer-to-Peer Genetics Support (provider-to-provider consultation), Patient Recruitment, and Sponsored Testing Programs. The company acquired GeneMatters in 2021 to expand telehealth genetic counseling capacity. Services are delivered via telehealth across all 50 U.S. states, supported by a patient portal for scheduling and records. The company serves patients, healthcare providers, hospitals/health systems, life sciences organizations, and genetic testing laboratories.

Product and service8 records
1Genetic Counseling
CategoryGenetic Services
Description

Telehealth-enabled genetic counseling sessions delivered by board-certified genetic counselors via phone or video across all 50 U.S. states, helping patients understand genetic testing options, interpret test results, and assess hereditary risk.

2Genetic Test Ordering
CategoryGenetic Services
Description

Service in which Genome Medical providers order medically appropriate genetic tests for U.S.-based patients, partnering with major genetic testing laboratories so patients and providers can work with their lab of choice.

3Clinical Trial Services
CategoryClinical Trial Services
Description

Clinical trial matching and recruitment service that identifies eligible patients based on genetic criteria, notifies them of relevant trial opportunities, and supports clinical trial feasibility analysis for sponsors.

4Peer-to-Peer Genetics Support
CategoryGenetic Services
Description

Provider-to-provider genetics consultation service that connects healthcare providers with Genome Medical genetics experts for support with testing decisions, interpretation of results, and patient care guidance.

5Patient Recruitment
CategoryClinical Trial Services
Description

Service for life sciences partners that identifies and recruits eligible patients based on genetic criteria, facilitating and accelerating clinical trial enrollment.

6Sponsored Testing Programs
CategoryGenetic Services
Description

Programs that expand genetic testing access, accelerate diagnosis, or confirm eligibility for clinical trials, typically delivered in partnership with life sciences organizations.

7GeneMatters
CategoryGenetic Services
Description

Telehealth genetic counseling solutions platform acquired by Genome Medical in August 2021, now operating as a Genome Medical subsidiary brand to expand clinical capacity for genetic counseling services.

8Family Testing Program
CategoryGenetic Services
Description

Genetic counseling and testing program for individuals with relatives who have a known genetic condition; includes initial consultation, saliva-based at-home testing kit, and results review with a genetic counselor.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Pharming, a biopharmaceutical company developing therapies for rare diseases, participated in a joint webinar with Genome Medical titled 'Bridging the Diagnosis Gap for Rare Disease Therapies'. Dr. Heather McLaughlin, Senior Director of Molecular Diagnostics at Pharming, was a featured speaker. Genome Medical has also published a case study with Pharming about how genetic counseling boosts engagement for rare disease diagnosis.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Tenaya Therapeutics, a company developing gene therapies for rare cardiac conditions, participated in a joint webinar with Genome Medical. Jeff Haroldson, Executive Director of Medical Affairs at Tenaya, was a featured speaker discussing genetic testing programs for individuals and families with hypertrophic cardiomyopathy (HCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC).

3Genetic Testing Laboratories
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Genome Medical partners with most major genetic testing laboratories, allowing patients and providers to work with their lab of choice. The company integrates genetic counseling and test ordering services with laboratory testing workflows, supporting appropriate test selection, ordering, and result interpretation.

genomemedical.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Genome Medical partners with hospitals and health systems — from large multi-site systems to smaller community hospitals — to help them reach more patients with genetic services. The partnership enables health systems to expand genetics care delivery without building in-house capacity.

5Life Sciences Organizations
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Genome Medical partners with life sciences organizations for product development, product launch, and market expansion initiatives. Services include patient recruitment for clinical trials, sponsored testing programs, clinical trial matching, and clinical trial feasibility analysis, helping identify and understand patient populations.

genomemedical.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Helix operates a population genomics platform with health-system partnerships for preventive genomics programs. Its model intersects with Genome Medical's life sciences and health-system service offerings.

TypeEmerging player
Description

PreventionGenetics is a clinical DNA testing laboratory offering rare-disease and hereditary cancer tests with clinical support. It is comparable as a genetic testing lab serving the same clinical specialties as Genome Medical.

TypeBroad incumbent
Description

Natera is a genetic testing company focused on reproductive health, oncology, and organ transplantation with growing clinical services and patient support functions. It is comparable as a major lab-adjacent clinical services provider.

TypeEmerging player
Description

23andMe is a consumer genetics company with a telehealth genetic counseling arm (Lemonaid Health integration) and a large genotype-phenotype database. It overlaps with Genome Medical on direct-to-patient genetic services and large-scale genetic data assets.

TypeBroad incumbent
Description

Invitae is a large-scale genetic testing laboratory offering hereditary cancer, rare disease, and reproductive health testing with integrated clinical services. As an established incumbent, it competes with Genome Medical across multiple test categories where counseling accompanies results.

TypeBroad incumbent
Description

Myriad is an established molecular diagnostics company with hereditary cancer, prenatal, and pharmacogenomic testing. Its integrated test-plus-services model overlaps with Genome Medical's hospital and life sciences partnerships.

TypeEmerging player
Description

Blueprint Genetics is a specialty genetics lab focused on inherited disease diagnostics with clinical interpretation services. It competes in the rare-disease genetic testing and clinical support market served by Genome Medical.

TypeDirect peer
Description

GeneDx is a clinical genomics lab delivering rare-disease and pediatric genetic testing with clinical interpretation and counseling support. It overlaps directly with Genome Medical in the rare-disease genetic services market.

TypeDirect peer
Description

Color Health combines genetic testing with virtual genetic counseling and clinical services delivered to patients, employers, and health systems. It is the closest direct peer to Genome Medical's telegenomics service model, with overlapping B2B and B2C channels.

TypeBroad incumbent
Description

Quest Diagnostics is a national reference lab that has expanded into genetic counseling services for its hereditary and reproductive genetic testing portfolio. It represents a large incumbent that could bundle or compete with telegenetic counseling offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors22 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genome Medical

Telehealth Genetic Servicesgenomemedical.com

Genome Medical is a telehealth-enabled genetics care delivery company providing genetic counseling, test ordering, clinical trial matching, and patient recruitment across all 50 U.S. states, serving hospitals, life sciences organizations, genetic testing labs, and individual patients.

What Genome Medical does

Genome Medical is a telehealth-enabled genetics care delivery company headquartered in South San Francisco, California. Founded in 2016, the company operates a nationwide telegenomics platform delivering genetic counseling, genetic test ordering, peer-to-peer provider support, clinical trial matching, and patient recruitment services across all 50 U.S. states. The company serves four primary customer segments: hospitals and health systems seeking to expand access to genetic services without building in-house capacity; life sciences organizations pursuing patient recruitment and clinical trial matching for genetic therapies; genetic testing laboratories requiring pre- and post-test counseling support; and individual patients and families navigating rare disease diagnoses—more than 50% of whom present with a rare disease indication. Genome Medical employs a clinical team of 35+ genetic counselors, medical geneticists, and physicians with an average of 10+ years of clinical experience and has delivered over 250,000 genetic counseling sessions with a 96% patient satisfaction rating.

The core technology is a HIPAA-compliant virtual medical practice platform that integrates telehealth (phone or video) genetic counseling, test ordering integrated with most major genetic testing laboratories, and a patient portal for scheduling and records management. Genome Medical acquired GeneMatters in August 2021 and operates it as a wholly-owned subsidiary. Revenue is generated through multiple streams: insurance billing as an in-network provider with major commercial health plans (Aetna, Anthem, BlueCross BlueShield, Cigna, United Healthcare); self-pay genetic counseling sessions at $250 each; and partnership agreements with health systems, genetic testing laboratories, and biopharmaceutical companies for sponsored testing programs, patient recruitment, and clinical trial feasibility analysis. Government-affiliated insurance (Medicaid, Medicare, Tricare) is not accepted.

Genome Medical has raised approximately $195 million across eight disclosed funding rounds from 2016 through 2024, including a $60 million Series C in August 2021 and an approximately $75.3 million exempt securities offering in September 2024. Notable institutional investors include Canaan Partners, Casdin Capital, Echo Health Ventures, Samsung Catalyst Fund, GE Ventures, Kaiser Permanente Ventures, Illumina Ventures, Google Ventures, and Amgen Ventures. The 2024 capital is allocated to expand services across the U.S. and into Canada, scale operations, enhance genetic counseling capacity, and develop partnerships with health systems, laboratories, and biopharmaceuticals. Leadership includes CEO Jill Davies alongside founders Lisa Alderson, Robert Green, and Randy Scott (Chairman).

Genome Medical firmographics

Firmographics
Name
Genome Medical
Legal name
Genome Medical, Inc.
Website
https://genomemedical.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
Genome Medical is a telehealth-enabled genetics care delivery company providing genetic counseling, test ordering, clinical trial matching, and patient recruitment across all 50 U.S. states, serving hospitals, life sciences organizations, genetic testing labs, and individual patients.
Ownership category
akta.pro rank

Genome Medical industry classification

Industry
Product category
Telehealth Genetic Services
NAICS
Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLALAHAK
Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAANAL
Population Genomics & Preventive Precision Health Programs

Keywords

  • Telehealth genetic counseling
  • Genomic medicine services
  • Genetic test ordering
  • Clinical trial matching
  • Rare disease diagnostics

Where Genome Medical is headquartered

Location

Headquarters

HQ city
South San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Genome Medical business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Genetic Counseling Services: Genome Medical bills insurance for genetic counseling sessions as an in-network provider with most commercial health insurance plans. Patients can also self-pay at $250 per session. The company also offers sponsored testing programs for life sciences partners, generating revenue through partnership agreements with health systems, genetic testing labs, and biopharmaceutical companies for patient recruitment and clinical trial matching services.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goInsurance-billed genetic counseling session
One time/ perpetual licensePay-as-you-goSelf-pay genetic counseling session

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Genome Medical product offering

Product offering

Core offering

Genome Medical is a telehealth-enabled genetics care delivery company providing virtual genetic counseling, genetic test ordering, and clinical trial matching services across all 50 U.S. states. The company delivers board-certified genetic counseling sessions via phone or video, integrates with major genetic testing laboratories to order tests, and partners with life sciences organizations to recruit patients for clinical trials. Its core clientele includes patients with rare diseases, hospitals and health systems, genetic testing laboratories, and biopharmaceutical companies.

Product overview

Genome Medical is a telehealth-enabled genetics care delivery company offering a platform of genetic services. The core offerings include Genetic Counseling (telehealth sessions with board-certified genetic counselors), Genetic Test Ordering (ordering tests through partnered labs), Clinical Trial Services (matching patients to trials), Peer-to-Peer Genetics Support (provider-to-provider consultation), Patient Recruitment, and Sponsored Testing Programs. The company acquired GeneMatters in 2021 to expand telehealth genetic counseling capacity. Services are delivered via telehealth across all 50 U.S. states, supported by a patient portal for scheduling and records. The company serves patients, healthcare providers, hospitals/health systems, life sciences organizations, and genetic testing laboratories.

Differentiator

Problem solved

Functional benefit

Brands

  • GeneMatters: A telehealth genetic counseling platform acquired by Genome Medical in 2021, now operating as a Genome Medical company.

Products and services

  • Genetic Counseling Telehealth-enabled genetic counseling sessions delivered by board-certified genetic counselors via phone or video across all 50 U.S. states, helping patients understand genetic testing options, interpret test results, and assess hereditary risk.
  • Genetic Test Ordering Service in which Genome Medical providers order medically appropriate genetic tests for U.S.-based patients, partnering with major genetic testing laboratories so patients and providers can work with their lab of choice.
  • Clinical Trial Services Clinical trial matching and recruitment service that identifies eligible patients based on genetic criteria, notifies them of relevant trial opportunities, and supports clinical trial feasibility analysis for sponsors.
  • Peer-to-Peer Genetics Support Provider-to-provider genetics consultation service that connects healthcare providers with Genome Medical genetics experts for support with testing decisions, interpretation of results, and patient care guidance.
  • Patient Recruitment Service for life sciences partners that identifies and recruits eligible patients based on genetic criteria, facilitating and accelerating clinical trial enrollment.
  • Sponsored Testing Programs Programs that expand genetic testing access, accelerate diagnosis, or confirm eligibility for clinical trials, typically delivered in partnership with life sciences organizations.
  • GeneMatters Telehealth genetic counseling solutions platform acquired by Genome Medical in August 2021, now operating as a Genome Medical subsidiary brand to expand clinical capacity for genetic counseling services.
  • Family Testing Program Genetic counseling and testing program for individuals with relatives who have a known genetic condition; includes initial consultation, saliva-based at-home testing kit, and results review with a genetic counselor.

Quantifiable outcome

  • Patients can meet with a genetic counselor within one week — compared to months-long waits typical of in-person genetics appointments.
  • +3 more outcomes

Companies that use Genome Medical

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Genome Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Genome Medical partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • PharmingminorStrategic or Co-development Partner · 1 January 2024Pharming, a biopharmaceutical company developing therapies for rare diseases, participated in a joint webinar with Genome Medical titled 'Bridging the Diagnosis Gap for Rare Disease Therapies'. Dr. Heather McLaughlin, Senior Director of Molecular Diagnostics at Pharming, was a featured speaker. Genome Medical has also published a case study with Pharming about how genetic counseling boosts engagement for rare disease diagnosis.
  • Tenaya TherapeuticsminorStrategic or Co-development Partner · 1 January 2024Tenaya Therapeutics, a company developing gene therapies for rare cardiac conditions, participated in a joint webinar with Genome Medical. Jeff Haroldson, Executive Director of Medical Affairs at Tenaya, was a featured speaker discussing genetic testing programs for individuals and families with hypertrophic cardiomyopathy (HCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC).
  • Genetic Testing LaboratoriescoreStrategic or Co-development PartnerGenome Medical partners with most major genetic testing laboratories, allowing patients and providers to work with their lab of choice. The company integrates genetic counseling and test ordering services with laboratory testing workflows, supporting appropriate test selection, ordering, and result interpretation.
  • Hospitals and Health SystemscoreStrategic or Co-development PartnerGenome Medical partners with hospitals and health systems — from large multi-site systems to smaller community hospitals — to help them reach more patients with genetic services. The partnership enables health systems to expand genetics care delivery without building in-house capacity.
  • Life Sciences OrganizationscoreStrategic or Co-development PartnerGenome Medical partners with life sciences organizations for product development, product launch, and market expansion initiatives. Services include patient recruitment for clinical trials, sponsored testing programs, clinical trial matching, and clinical trial feasibility analysis, helping identify and understand patient populations.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Genome Medical competitors and assessment

Company assessment

Emerging players

  • Helix: Helix operates a population genomics platform with health-system partnerships for preventive genomics programs. Its model intersects with Genome Medical's life sciences and health-system service offerings.
  • PreventionGenetics (part of Exact Sciences): PreventionGenetics is a clinical DNA testing laboratory offering rare-disease and hereditary cancer tests with clinical support. It is comparable as a genetic testing lab serving the same clinical specialties as Genome Medical.
  • 23andMe: 23andMe is a consumer genetics company with a telehealth genetic counseling arm (Lemonaid Health integration) and a large genotype-phenotype database. It overlaps with Genome Medical on direct-to-patient genetic services and large-scale genetic data assets.
  • Blueprint Genetics: Blueprint Genetics is a specialty genetics lab focused on inherited disease diagnostics with clinical interpretation services. It competes in the rare-disease genetic testing and clinical support market served by Genome Medical.

Broad incumbents

  • Natera: Natera is a genetic testing company focused on reproductive health, oncology, and organ transplantation with growing clinical services and patient support functions. It is comparable as a major lab-adjacent clinical services provider.
  • Invitae: Invitae is a large-scale genetic testing laboratory offering hereditary cancer, rare disease, and reproductive health testing with integrated clinical services. As an established incumbent, it competes with Genome Medical across multiple test categories where counseling accompanies results.
  • Myriad Genetics: Myriad is an established molecular diagnostics company with hereditary cancer, prenatal, and pharmacogenomic testing. Its integrated test-plus-services model overlaps with Genome Medical's hospital and life sciences partnerships.
  • Quest Diagnostics (Genetic Counselors / Quiete): Quest Diagnostics is a national reference lab that has expanded into genetic counseling services for its hereditary and reproductive genetic testing portfolio. It represents a large incumbent that could bundle or compete with telegenetic counseling offerings.

Direct peers

  • GeneDx (formerly Sema4): GeneDx is a clinical genomics lab delivering rare-disease and pediatric genetic testing with clinical interpretation and counseling support. It overlaps directly with Genome Medical in the rare-disease genetic services market.
  • Color Health: Color Health combines genetic testing with virtual genetic counseling and clinical services delivered to patients, employers, and health systems. It is the closest direct peer to Genome Medical's telegenomics service model, with overlapping B2B and B2C channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Genome Medical social profiles

Digital presence

Genome Medical compliance and trust

Trust signal

Compliance1 record

Genome Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genome Medical leadership team

Management profile

Number of profiles

Profiles6 records

Genome Medical subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Genome Medical funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors22 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genome Medical M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genome Medical

What does Genome Medical do?

Genome Medical is a telehealth-enabled genetics care delivery company providing virtual genetic counseling, genetic test ordering, and clinical trial matching services across all 50 U.S. states. The company delivers board-certified genetic counseling sessions via phone or video, integrates with major genetic testing laboratories to order tests, and partners with life sciences organizations to recruit patients for clinical trials. Its core clientele includes patients with rare diseases, hospitals and health systems, genetic testing laboratories, and biopharmaceutical companies.

Is Genome Medical a public or private company?

Genome Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Genome Medical founded?

Genome Medical was founded in 2016. It employs 51 to 100 people.

Where is Genome Medical based?

Genome Medical is headquartered in South San Francisco, United States, in the North America region.

How does Genome Medical make money?

One revenue line is on record: genetic Counseling Services.

Who are Genome Medical's main competitors?

Emerging players on record are Helix, PreventionGenetics (part of Exact Sciences), 23andMe and Blueprint Genetics. Broad incumbents are Natera, Invitae, Myriad Genetics and Quest Diagnostics (Genetic Counselors / Quiete). Direct peers are GeneDx (formerly Sema4) and Color Health.

Does Genome Medical have an API?

No public API is recorded for Genome Medical.

What industry is Genome Medical in?

Genome Medical's product category is Telehealth Genetic Services. Its primary akta.pro industry code is HLALAHAK, Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling), with a secondary code of HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support). Its NAICS code is 6215 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioengineeringBlood virome study links herpesviruses and immune activation to ischemicResearchers at the University of Alberta discovered that blood from ischemic stroke patients contains significantly higher levels of active herpesvirus genetic material than that of healthy individuals. The study, published in Genome Medicine, found that stroke patients had 2.13-fold more herpesvirus transcripts and exhibited patterns suggesting coordinated immune dysregulation linked to altered host immune signaling. While the observational data cannot prove causation, these findings suggest dormant viruses may amplify the inflammatory response during a stroke, potentially opening new avenues for prevention or treatment.EIN PresswireGenome Medical Releases New White Paper Revealing Critical Gaps in Inherited Retinal Disease CareGenome Medical released a white paper on inherited retinal disease care, finding nearly half of surveyed patients waited over five years for genetic testing. The report notes 74% of tested patients confirmed their diagnosis, but navigational and financial barriers persist. It highlights over 30 therapeutic programs in development and calls for ecosystem collaboration to improve access.EIN PresswireNew Patient Insights Reveal Opportunities for Rare Epilepsy CareGenome Medical released a white paper titled 'Genetic Epilepsies: Voice of the Patient and Family' that draws on patient and caregiver surveys alongside peer-reviewed research to examine barriers in genetic epilepsy diagnosis and care. The report identifies four key themes: prolonged diagnostic journeys with some families waiting more than five years for a molecular diagnosis, gaps in genetic testing access due to cost and lack of knowledge, disease burden extending beyond seizures, and a growing precision therapy pipeline that many families have not accessed. Nearly three-quarters of caregivers reported moderate or significant effects on their own wellbeing, and two-thirds left or adjusted employment to accommodate caregiving.GenomemedicalWhat is the Cost of Genetic Counseling and Genetic Testing?Genome Medical, a genetic counseling provider, published an informational guide explaining the costs associated with their services, including initial counseling visits priced at up to $250 out-of-pocket (approximately $75 with insurance coverage) and follow-up appointments for reviewing test results. The company requires a genetic counseling session before ordering any genetic tests, which are performed by separate laboratories whose fees vary and must be obtained directly from those labs. Genome Medical is in-network with many major commercial insurers but does not accept Medicare, Medicaid, or Tricare, and advises patients to confirm coverage details with their insurance providers before scheduling.Nasdaq Private MarketSell or Invest in Genome Medical Stock Pre-IPOThe article provides instructions for accredited investors and employees on how to buy or sell private shares of Genome Medical through the Nasdaq Private Market. It clarifies that Genome Medical is a privately held company without a public stock price, ticker symbol, or IPO status. The text serves as an informational guide regarding eligibility and settlement processes for trading these specific private securities.ForbesThe ROI Of AI Medicine—Where Custom Cures Meet Smart MoneyAI is enabling personalized medicine for rare diseases, with startups like Nome using AI to map treatment options. The global AI-in-drug-discovery market is projected to reach $20.3 billion by 2030, and Nome recently announced a funding round and partnership with Genome Medical. Regulatory clarity is needed for pricing and payment of these therapies.GenomemedicalWho We SupportThe provided text consists primarily of cookie consent notices, privacy policy details, and website navigation artifacts rather than a coherent news article. It contains boilerplate information about data tracking by services like Cloudflare, HubSpot, and Google Analytics, along with a brief promotional segment for Genome Medical.GenomemedicalAdvancing Rare Disease Care TogetherGenome Medical promotes telehealth genetic counseling and testing services for individuals with rare genetic conditions, emphasizing quick access and clinical trial opportunities. The organization highlights its extensive experience, including over 250,000 counseling sessions and a high patient satisfaction rating.GenomemedicalGenome Medical and Nest Genomics Partner to Scale Access to Genetic Services and Improve Patient CareGenome Medical and Nest Genomics have entered a partnership to integrate genetic services into Nest's digital health platform, aiming to improve patient access and clinical decision-making. The collaboration allows healthcare providers to seamlessly refer patients for genetic counseling, test ordering, and clinical trial matching directly through the Nest system. This initiative seeks to streamline workflows and enhance personalized care by combining Genome Medical’s clinical expertise with Nest Genomics’ scalable software infrastructure.SpringerLinkValidation of a guidelines-based digital tool to assess the need for germline cancer genetic testing - Hereditary Cancer in Clinical PracticeA study validated the clinical accuracy of RISE Risk Assessment Module: Hereditary Cancer, a digital tool developed by Genome Medical for assessing germline cancer genetic testing eligibility. The tool demonstrated a 96% agreement rate with board-certified genetic counselors across 152 patient cases, confirming its validity in identifying individuals who meet national guideline criteria.